NCT03338933View on ClinicalTrials.gov

Neurobiology of Alcohol and Nicotine Co-Addiction

CompletedOBSERVATIONAL

Enrollment

109

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

January 3, 2023

Study Completion Date

January 3, 2023

Conditions

Alcohol Use DisorderNicotine Use Disorder

Interventions

BEHAVIORAL

magnetic resonance imaging (MRI)

All subjects will undergo a baseline MRI and subjects in both alcohol groups (alcohol use disorder and combined alcohol and nicotine use disorder) will undergo a followup MRI 3 months after baseline.

Trial Locations (1)

97207-2964

VA Portland Health Care System, Portland, OR, Portland

All Listed Sponsors

collaborator

Oregon Health and Science University

OTHER

lead

VA Office of Research and Development

FED

NCT03338933 - Neurobiology of Alcohol and Nicotine Co-Addiction | Biotech Hunter | Biotech Hunter